Stay updated with the Cipla Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

Stay informed with the Cipla Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a ...

Shares of Cipla Ltd came under pressure on Wednesday, falling nearly 4% in afternoon trade following the company's September quarter (Q2FY26) earnings announcement. At 1:49 p.m., Cipla's stock was ...

Prabhudas Lilladher recommended accumulate rating on Cipla with a target price of Rs 1675 in its research report dated October 31, 2025.

Cipla said the acquisition is a strategic move aimed at integrating Inzpera’s differentiated portfolio of paediatric pharmaceutical and wellness products with Cipla’s strong distribution network and ...

Torrent Pharma market capitalisation stood at ₹1.28 trillion on Monday, while that of Cipla at ₹1.22 trillion, shows BSE.

Discover key stock movers as top Indian firms report earnings, acquisitions, and fundraises—track major business updates now!

Indian multinational pharmaceutical giant, Cipla, shares dropped more than 4% during the intraday trading session on Thursday, 30 October 2025, after the company announced its July-September quarter ...

Cipla Ltd is up for a fifth straight session today. The stock is quoting at Rs 1524.9, up 0.37% on the day as on 12:44 IST on ...

Cipla has now entered into obesity Market with a partnership with Eli Lilly for Tirzepatide (GLP-1) is exclusive to the Indian market.

Zee Business provides the latest business news such as Indian stock market news and Updates, sensex live news & nifty news.

Cipla acquires Inzpera Healthsciences for Rs 110 crore, enhancing its paediatric product portfolio and distribution ...